Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation

Fig. 7

Effect of iMSCs-EVs administration on the percentages of Th17 and Treg cells in peripheral blood and spleen. a, b, e, and f Representative flow cytometric plots in each group. c, d Statistical results indicated that iMSCs-EVs administration could increase the percentages of Treg cells. g, h Statistical results indicated that iMSCs-EVs administration could reverse the increases in the percentages of Th17 cells. Data are presented as the mean ± SD, *P < 0.05, n.s. indicates no significance

Back to article page